FDA Adverse Event Injury Summary report: N

TOTAL ASR ACET IMP SIZE 48

MDR report key: 2935665 · Received January 30, 2013

Report

Report Number
1818910-2013-01829
Event Type
Injury
Date Received
January 30, 2013
Date of Event
January 24, 2011
Report Date
November 17, 2014
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KWA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA.

Description of Event or Problem · 1

ASR REVISION; ASR XL - RIGHT HIP; REASON FOR REVISION: PAIN.

Description of Event or Problem · 1

NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGACY SYSTEM) COMPLAINT NUMBER (B)(4) REASON FOR ORIGINAL COMPLAINT - ASR REVISION, ASR XL - RIGHT, REASON(S) FOR REVISION: PAIN. UPDATE - ADDED A STEM AND SLEEVE TAKEN FROM CLAIMSUITE DATED 25TH FEB 2013. UPDATE - ADDED ADDITIONAL REASON FOR REVISION. TAKEN FROM CLAIMSUITE DATED 17TH NOV 2014. REASON(S) FOR REVISION: PAIN; ALVAL / SOFT TISSUE REACTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
40098 TOTAL ASR ACET IMP SIZE 48 HIP ACETABULAR CUP KWA DEPUY INTERNATIONAL LTD. 8010379 2805316

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention